Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design

Paesmans Marianne, Grigoriu Bogdan, Ocak Sebahat, Roelandts Martine, Lafitte Jean-Jacques, Holbrechts Stéphane, Berghmans Thierry, Meert Anne-Pascale, Moretti Luigi, Danyi Sophie, Pasleau Françoise, Ameye Lieveke, Van Meerhaeghe Alain, Sculier Jean-Paul

Source: Eur Respir J 2015; 45: 511-524
Journal Issue: February

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Paesmans Marianne, Grigoriu Bogdan, Ocak Sebahat, Roelandts Martine, Lafitte Jean-Jacques, Holbrechts Stéphane, Berghmans Thierry, Meert Anne-Pascale, Moretti Luigi, Danyi Sophie, Pasleau Françoise, Ameye Lieveke, Van Meerhaeghe Alain, Sculier Jean-Paul. Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design. Eur Respir J 2015; 45: 511-524

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bevacizumab as first line treatment for advanced non-small cell lung cancer (NSCLC): a meta-analysis of randomised placebo-controlled trials (RCTs)
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008



Sequential screening for lung cancer in a high-risk group: randomised controlled trial
Source: Eur Respir J, 54 (4) 1900581; 10.1183/13993003.00581-2019
Year: 2019



The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


Cost-effectiveness analysis of three strategies of erlotinib treatment in non small-cell lung cancer: A prospective multicentric French study (ERMETIC)
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Pilot trial of the ICHOM lung cancer standard set
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017

Home-based rehabilitation in inoperable lung cancer: a randomised controlled trial
Source: International Congress 2018 – Physiotherapy care for patients with acute and chronic respiratory conditions
Year: 2018




Pre-operative chemotherapy in patients with resectable non-small cell lung cancer (NSCLC): the MRC LU22/NVALT/EORTC 08012 multi-centre randomised trial
Source: Eur Respir J 2007; 30: Suppl. 51, 240s
Year: 2007

Screening for lung cancer with low dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials
Source: Annual Congress 2010 - Epidemiology of lung cancer
Year: 2010

The big lung trial (BLT): a major randomised trial examining the role of cisplatin-based chemotherapy in all stages of non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting
Source: Eur Respir J 2002; 20: Suppl. 38, 399s
Year: 2002

Pembrolizumab versus nivolumab as second and further line treatment in non-small cell lung cancer; a retrospective single-centre study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020


Pemetrexed in the first line treatment in non-small cell lung cancer (NSCLC): A multicentre prospective analysis of data from clinical practise of Czech Republic
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


Early detection of lung cancer – the NELSON trial results into real-life practice
Source: ERS webinars 2019 - Early detection of lung cancer – the NELSON trial results into real-life practice
Year: 2019


Short-time exercise-induced rehabilitation in non-small cell lung cancer patients during in-hospital chemotherapy treatment: a randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006

Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I – IIIa nonsmall cell lung cancer conducted by the European lung cancer working party
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003

Determinants of completion of a home-based rehabilitation program in patients awaiting lung surgery for lung cancer : a prospective observational multicenter study
Source: Virtual Congress 2020 – Thoracic surgery: malignancies
Year: 2020


Augmentation therapy for α1-antitrypsin deficiency: a meta-analysis of randomized and non-randomized clinical studies
Source: Eur Respir J 2005; 26: Suppl. 49, 288s
Year: 2005

Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs)
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis.
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021